These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29339392)

  • 1. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
    Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperazine-Derivative MMV665917: An Effective Drug in the Diarrheic Piglet Model of Cryptosporidium hominis.
    Lee S; Ginese M; Girouard D; Beamer G; Huston CD; Osbourn D; Griggs DW; Tzipori S
    J Infect Dis; 2019 Jun; 220(2):285-293. PubMed ID: 30893435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model.
    Stebbins E; Jumani RS; Klopfer C; Barlow J; Miller P; Campbell MA; Meyers MJ; Griggs DW; Huston CD
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006183. PubMed ID: 29309415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.
    Bessoff K; Spangenberg T; Foderaro JE; Jumani RS; Ward GE; Huston CD
    Antimicrob Agents Chemother; 2014 May; 58(5):2731-9. PubMed ID: 24566188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel treatment strategies and drugs in development for cryptosporidiosis.
    Chavez MA; White AC
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
    Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
    Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin.
    Oboh E; Schubert TJ; Teixeira JE; Stebbins EE; Miller P; Philo E; Thakellapalli H; Campbell SD; Griggs DW; Huston CD; Meyers MJ
    J Med Chem; 2021 Aug; 64(15):11729-11745. PubMed ID: 34342443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein.
    Liu M; Zhang D; Wang D; Wu X; Zhang Y; Yin J; Zhu G
    J Infect Dis; 2023 Nov; 228(10):1430-1440. PubMed ID: 37418629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
    Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis.
    Lunde CS; Stebbins EE; Jumani RS; Hasan MM; Miller P; Barlow J; Freund YR; Berry P; Stefanakis R; Gut J; Rosenthal PJ; Love MS; McNamara CW; Easom E; Plattner JJ; Jacobs RT; Huston CD
    Nat Commun; 2019 Jun; 10(1):2816. PubMed ID: 31249291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
    Rueda C; Fenoy S; Simón F; Del Aguila C
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
    Nachipo P; Hermann D; Quinnan G; Gordon MA; Van Voorhis WC; Iroh Tam PY
    Trials; 2018 Aug; 19(1):456. PubMed ID: 30139372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging treatment options for cryptosporidiosis.
    Love MS; Choy RKM
    Curr Opin Infect Dis; 2021 Oct; 34(5):455-462. PubMed ID: 34261904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Existing Drug Vorinostat as a New Lead Against Cryptosporidiosis by Targeting the Parasite Histone Deacetylases.
    Guo F; Zhang H; McNair NN; Mead JR; Zhu G
    J Infect Dis; 2018 Mar; 217(7):1110-1117. PubMed ID: 29300993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
    Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of
    Buckner FS; Ranade RM; Gillespie JR; Shibata S; Hulverson MA; Zhang Z; Huang W; Choi R; Verlinde CLMJ; Hol WGJ; Ochida A; Akao Y; Choy RKM; Van Voorhis WC; Arnold SLM; Jumani RS; Huston CD; Fan E
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth
    Funkhouser-Jones LJ; Ravindran S; Sibley LD
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.